Each year, cardiovascular and metabolic diseases cause millions of deaths worldwide. Despite the therapeutic advances, just a limited number of options are available for the treatment of metabolic and heart diseases.

Janssen has the permanent commitment of carrying out research surrounding the prevention and treatment of cardiovascular and metabolic diseases. Our objective is to develop innovative health solutions that significantly improve the results for the patients. We are building an integral approach in care for patients with diabetes and cardiovascular disease.